Semigran Marc 4
4 · Edgewise Therapeutics, Inc. · Filed Aug 18, 2023
Insider Transaction Report
Form 4
Semigran Marc
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-08-17+133,333→ 133,333 totalExercise: $7.08Exp: 2033-08-17→ Common Stock (133,333 underlying)
Footnotes (1)
- [F1]1/48th of the shares subject to the option vest each month beginning on September 17, 2023, subject to the Reporting Person continuing as a service provider through each vest date.